10 AbbVie legal leaders
Patents, AI and R&D show up in the titles of four AbbVie legal leaders here (IP Strategy, AI and two R&D Innovation Legal posts), next to two Vice Presidents, Legal, a senior associate general counsel for IP transactions, one for Global Commercial, a corporate governance counsel and the Legal Director ANZ. All ten are in their AbbVie roles now, which suits questions on patent strategy, FDA-facing R&D work, AI governance and board matters at a drug company.
Professionals to explore
Christo Siebrits
LinkedInExperience: Senior Associate General Counsel, Head of AI · AbbVie
$673 per 30-minute call
Christo Siebrits leads AI governance and strategy at AbbVie as Senior Associate General Counsel, Head of AI, since 2024. Regional roles came before: Area Counsel, International Markets (Canada, LATAM, JAPAC, Russia CIS and MEA) at AbbVie (2017-2024), Regional Legal Counsel EMEA there (2013-2017), Legal Director (EE, MEA, Russia) at AstraZeneca (2010-2013) and Regional Legal Director for Africa and Middle East at Reckitt (2008-2010). AI governance questions fit Siebrits.
Is this you? Claim your profile and get paid for calls.
Dan Hoang
LinkedInExperience: Former Senior Associate General Counsel - Global Commercial · AbbVie
$539 per 30-minute call
Dan Hoang became Senior Associate General Counsel - Global Commercial at AbbVie in 2026 after Associate General Counsel - Patent Litigation (2022-2026) and Senior Counsel - Patent Litigation (2021-2022). Before AbbVie, Hoang was a Litigation Associate at Winston & Strawn LLP (2011-2021) and a Renal Research Intern at Baxter International Inc. (2007). Commercial legal questions, and the move from patent litigation into commercial work, fit Hoang.
Is this you? Claim your profile and get paid for calls.
Eleanor Mayer
LinkedInExperience: Former Associate General Counsel, R&D Innovation Legal · AbbVie
$539 per 30-minute call
Eleanor Mayer moved to AbbVie as Associate General Counsel, R&D Innovation Legal in 2025 after a run of FDA roles: Deputy Associate Director for Policy, Center for Biologics Evaluation and Research (2024-2025), Senior Counsel, Office of the Chief Counsel (2023-2024), Senior Advisor (Acting), Office of Policy, Legislation, and International Affairs (2023) and Associate Chief Counsel, Office of the Chief Counsel (2014-2023). FDA policy and biologics questions fit Mayer.
Is this you? Claim your profile and get paid for calls.
jessica kanevsky
LinkedInExperience: Legal Director ANZ · AbbVie
$404 per 30-minute call
Based in the Greater Sydney Area, jessica kanevsky is Legal Director ANZ at AbbVie since 2024, after Head of Legal ANZ (2018-2024) and Legal Counsel (2014-2018) there. Earlier roles were Legal Counsel at Eli Lilly and Company (2012-2014) and associate at Norton Rose Fulbright (2008-2012). Questions on running a country legal team at AbbVie, and on how regional counsel work with headquarters, fit this record.
Is this you? Claim your profile and get paid for calls.
Lara Levitan
LinkedInExperience: Vice President, Legal · AbbVie
$1,211 per 30-minute call
Lara Levitan is Vice President, Legal at AbbVie since 2015 and Vice President and Associate General Counsel since 2013, leading a team of attorneys and paraprofessionals and giving legal advice to an R&D organization with a $3 billion R&D budget. Abbott roles were Divisional Vice President and Associate General Counsel, Pharmaceutical Products Legal Operations (2010-2013) and Associate General Counsel and DVP, Commercial Legal Operations (2009-2010). R&D legal questions fit.
Is this you? Claim your profile and get paid for calls.
Michael Montgomery
LinkedInExperience: Senior Associate General Counsel, Head of IP Strategy · AbbVie
$606 per 30-minute call
Michael Montgomery leads the IP Strategy group as Senior Associate General Counsel, Head of IP Strategy at AbbVie since 2025. Earlier AbbVie roles were Associate General Counsel, IP Litigation (2024-2025), Senior Counsel, IP Litigation (2022-2024), Senior Counsel, IP Strategy (2021-2022) and Patent Counsel (2017-2021), with experience in patent prosecution, litigation, diligence and transactional work. Patent portfolio strategy questions fit Montgomery.
Is this you? Claim your profile and get paid for calls.
Pearson Bownas
LinkedInExperience: Vice President, Legal - Litigation, Compliance & Regulatory · AbbVie
$1,078 per 30-minute call
Pearson Bownas holds Vice President, Legal - Litigation, Compliance & Regulatory at AbbVie since 2015 and Vice President & Associate General Counsel - Litigation & Compliance since 2014. Earlier came Senior Counsel, Litigation at AbbVie (2013-2014), Senior Counsel, Commercial Litigation at Abbott (2011-2012) and Adjunct professor at the Case Western Reserve University School of Law (2009-2011). Litigation, compliance and regulatory questions fit Bownas.
Is this you? Claim your profile and get paid for calls.
Sonali Srivastava
LinkedInExperience: Senior Associate General Counsel · AbbVie
$505 per 30-minute call
Sonali Srivastava, a patent prosecutor, is Senior Associate General Counsel at AbbVie since 2024 and leads IP negotiations and diligence for immunology, neuropsychiatry and specialty transactions, the trademark team and an AI Think Tank on intellectual property. Earlier roles were Division Counsel at AbbVie Inc. (2013-2024), Senior Counsel at Abbott (2006-2013) and Attorney at Law at Godfrey & Kahn (2001-2006). Deal diligence questions on IP fit.
Is this you? Claim your profile and get paid for calls.
T.O. Odutayo
LinkedInExperience: Associate General Counsel, Corporate Governance · AbbVie
$505 per 30-minute call
T.O. Odutayo is Associate General Counsel, Corporate Governance at AbbVie since 2026, and has held three AbbVie titles in Securities & Finance: Associate General Counsel (2025-2026), Senior Counsel (2023-2025) and Counsel (2021-2023). Before AbbVie, Odutayo was an Associate Attorney at Locke Lord LLP (2020-2021). Corporate governance, securities law compliance, capital markets and M&A are named areas, a fit for board and disclosure questions.
Is this you? Claim your profile and get paid for calls.
Trang Hoang Lin
LinkedInExperience: Senior Associate General Counsel - R&D Innovation Legal · AbbVie
$539 per 30-minute call
Trang Hoang Lin holds Senior Associate General Counsel - R&D Innovation Legal at AbbVie since 2025, after Associate General Counsel - R&D Strategy Legal (2023-2025). At Rakoczy Molino Mazzochi Siwik LLP, Lin was Partner (2017-2023) and Attorney (2012-2023), and earlier a Patent Attorney at Fresenius Kabi USA (2011-2012). Questions where R&D strategy meets patent law fit Lin, who is based in the Greater Chicago Area.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
Patent questions split three ways: Michael Montgomery for IP strategy, Sonali Srivastava for IP diligence in deals, and Dan Hoang for patent litigation experience. R&D Innovation Legal questions go to Trang Hoang Lin or to Eleanor Mayer, who brings FDA policy and counsel roles; Christo Siebrits covers AI governance, and T.O. Odutayo is the one for board and securities matters.
Questions to take into the conversation
- 01How does a drug company's IP team run patent diligence when in-licensing an immunology or neuroscience asset?
- 02What does an AI governance program inside a pharmaceutical legal department review before a new AI tool goes live?
- 03How do R&D legal counsel prepare a development team for questions from FDA reviewers on a new biologic?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.